{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:27:51Z","timestamp":1760898471128,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s10147-018-1325-0","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T09:29:42Z","timestamp":1533115782000},"page":"1134-1139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of everolimus treatment for regrown renal angiomyolipoma associated with tuberous sclerosis complex after transcatheter arterial embolization"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8163-0087","authenticated-orcid":false,"given":"Takashi","family":"Hatano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishi","family":"Matsu-ura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei-ichiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhisa","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Tamari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Egawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,1]]},"reference":[{"key":"1325_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","volume":"615","author":"JP Osborne","year":"1991","unstructured":"Osborne JP, Fryer A, Webb DW (1991) Epidemiology of tuberous sclerosis. Ann NY Acad Sci 615:125\u2013127","journal-title":"Ann NY Acad Sci"},{"key":"1325_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M Slegtenhorst van","year":"1997","unstructured":"van Slegtenhorst M, de Hoogt R, Hermans C et al (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805\u2013808","journal-title":"Science"},{"key":"1325_CR3","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","volume":"75","author":"The European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","unstructured":"The European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305\u20131315","journal-title":"Cell"},{"key":"1325_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","volume":"372","author":"P Curatolo","year":"2008","unstructured":"Curatolo P, Bombardieri R, Jozwiak S (2008) Tuberous sclerosis. Lancet 372:657\u2013658","journal-title":"Lancet"},{"key":"1325_CR5","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/j.juro.2007.07.058","volume":"178","author":"M Castagnetti","year":"2007","unstructured":"Castagnetti M, Vezzu B, Laverda A et al (2007) Urological counseling and follow up in pediatric tuberous sclerosis complex. J Urol 178:2155\u20132159","journal-title":"J Urol"},{"key":"1325_CR6","doi-asserted-by":"publisher","first-page":"e63910","DOI":"10.1371\/journal.pone.0063910","volume":"8","author":"MW Kaneda","year":"2013","unstructured":"Kaneda MW, Tanaka M, Hamasaki T et al. (2013) Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients. PLoS One 8:e63910","journal-title":"PLoS One"},{"key":"1325_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1071-9091(98)80005-3","volume":"5","author":"HP Neumann","year":"1998","unstructured":"Neumann HP, Schwarzkopf G, Henske EP (1998) Renal angiomyolipomas, cysts, and cancer in tuberous sclerosis complex. Semin Pediatr Neurol 5:269\u2013275","journal-title":"Semin Pediatr Neurol"},{"key":"1325_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.diii.2013.01.003","volume":"94","author":"O Rouviere","year":"2013","unstructured":"Rouviere O, Nivet H, Grenier N et al. (2013) Kidney damage due to tuberous sclerosis complex: management recommendations. Diagn Interv Imaging 94:225\u2013237","journal-title":"Diagn Interv Imaging"},{"key":"1325_CR9","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/iju.13168","volume":"23","author":"T Hatano","year":"2016","unstructured":"Hatano T, Chikaraishi K, Inaba Y et al. (2016) Outcomes of everolimus treatment for renal angiomyolipoma with tuberous sclerosis complex: a single institution experience in Japan. Int J Urol 23:833\u2013838","journal-title":"Int J Urol"},{"key":"1325_CR10","first-page":"255265","volume":"48","author":"DA Krueger","year":"2013","unstructured":"Krueger DA, Northrup H, International Tuberous Sclerosis Complex Consensus Group (2013) Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediat Neurol 48:255\u2013265","journal-title":"Pediat Neurol"},{"key":"1325_CR11","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1097\/01.ju.0000177497.31986.64","volume":"174","author":"DH Ewalt","year":"2005","unstructured":"Ewalt DH, Diamond N, Rees C et al (2005) Long term outcome of transcatheter embolization of renal angiomyolipomas due to tuberous sclerosis complex. J Urol 174:1764\u20131766","journal-title":"J Urol"},{"key":"1325_CR12","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","volume":"70","author":"SK Rakowski","year":"2006","unstructured":"Rakowski SK, Winterkorn EB, Paul E et al (2006) Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int 70:1777\u20131782","journal-title":"Kidney Int"},{"key":"1325_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","volume":"381","author":"JJ Bissler","year":"2013","unstructured":"Bissler JJ, Kingswood JC, Radzikowska E et al (2013) Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicenter, randomized, double-blind, placebo-controlled trial. Lancet 381:817\u2013824","journal-title":"Lancet"},{"key":"1325_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/ndt\/gfv249","volume":"31","author":"JJ Bissler","year":"2016","unstructured":"Bissler JJ, Kingswood JC, Radzikowska E et al (2016) Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized, controlled trial. Nephrol Dial Transplant 31:111\u2013119","journal-title":"Nephrol Dial Transplant"},{"key":"1325_CR15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10147-017-1224-9","volume":"23","author":"T Hatano","year":"2018","unstructured":"Hatano T, Atsuta M, Inaba Y, Endo K, Egawa S (2018) Effect of everolimus treatment for renal angiomyolipoma with tuberous sclerosis complex: an evaluation based on tumor density. Int J Clin Oncol 23:547\u2013552","journal-title":"Int J Clin Oncol"},{"key":"1325_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1148\/radiol.2251011477","volume":"225","author":"K Yamakado","year":"2002","unstructured":"Yamakado K, Tanaka N, Nakagawa T, Kobayashi S, Yanagawa M, Takeda T (2002) Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology 225:78\u201382","journal-title":"Radiology"},{"key":"1325_CR17","first-page":"PD05","volume":"9","author":"S Kumar","year":"2015","unstructured":"Kumar S, Jayant K, Singh SK, Agrawal S (2015) A case series & review of literature of angiomyolipoma with medical & surgical perspective. J Clin Diagn Res 9:PD05\u2013PD07","journal-title":"J Clin Diagn Res"},{"key":"1325_CR18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.4329\/wjr.v8.i3.308","volume":"8","author":"RA Sheth","year":"2016","unstructured":"Sheth RA, Feldman AS, Paul E et al. (2016) Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipoma in tuberous sclerosis. World J Radiol 8:308\u2013315","journal-title":"World J Radiol"},{"key":"1325_CR19","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.oraloncology.2009.08.006","volume":"45","author":"ST Sonis","year":"2009","unstructured":"Sonis ST (2009) Mucositis: the impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol 45:1015\u20131020","journal-title":"Oral Oncol"},{"key":"1325_CR20","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1186\/1471-2407-14-906","volume":"14","author":"SH Ha","year":"2014","unstructured":"Ha SH, Park JH, Jang HR et al (2014) Increased risk of everolimus-associated acute kidney injury in cancer patients with impaired kidney function. BMC Cancer 14:906","journal-title":"BMC Cancer"},{"key":"1325_CR21","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/iju.13428","volume":"24","author":"T Hatano","year":"2017","unstructured":"Hatano T, Inaba Y, Endo K, Egawa S (2017) Intermittent everolimus administration for renal angiomyolipoma with tuberous sclerosis complex. Int J Urol 24:780\u2013785","journal-title":"Int J Urol"},{"key":"1325_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2490-14-77","volume":"14","author":"T Krummel","year":"2014","unstructured":"Krummel T, Garmon J, Lang H, Gangi A, Hannedouche T (2014) Percutaneous cryoablation for tuberous sclerosis-associated renal angiomyolipoma with neoadjuvant mTOR inhibition. BMC Urol 14:77","journal-title":"BMC Urol"},{"key":"1325_CR23","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1177\/0284185113475441","volume":"54","author":"BK Park","year":"2013","unstructured":"Park BK, Kim CK, Park SY, Shen S (2013) Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes. Acta Radiol 54:418\u2013427","journal-title":"Acta Radiol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-018-1325-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-018-1325-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-018-1325-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T20:55:31Z","timestamp":1564606531000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-018-1325-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1325"],"URL":"https:\/\/doi.org\/10.1007\/s10147-018-1325-0","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"type":"print","value":"1341-9625"},{"type":"electronic","value":"1437-7772"}],"subject":[],"published":{"date-parts":[[2018,8,1]]},"assertion":[{"value":"1 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors of this article declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}